prostate_001:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma
  biomarker_profile: "BRCA2 germline mutation detected (c.5946delT). MSI-stable. TMB low (2 mut/Mb)."

prostate_002:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic adenocarcinoma
  biomarker_profile: "No actionable mutations identified in BRCA1, BRCA2, or PALB2."

prostate_003:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Small cell carcinoma of the prostate
  biomarker_profile: "TP53 p.R273H mutation detected at 45% VAF. Neuroendocrine markers positive: chromogranin A elevated, synaptophysin positive."

prostate_004:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate cancer
  biomarker_profile: "MSI-H detected. TMB elevated at 18 mutations/Mb. MLH1/PMS2 loss by IHC."

prostate_005:
  morphology: ADENOCARCINOMA
  descriptive_name: Acinar adenocarcinoma
  biomarker_profile: "BRCA1 somatic mutation p.Q1756fs detected. BRCA2 wild-type. Homologous recombination deficiency score positive."

prostate_006:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate ADC
  biomarker_profile: "Comprehensive genomic profiling negative for all tested alterations."

prostate_007:
  morphology: ADENOCARCINOMA
  descriptive_name: Metastatic castration-resistant prostate cancer
  biomarker_profile: "BRCA2 biallelic loss confirmed. PALB2 WT. TP53 R175H mutation (32% allele frequency). MSS. TMB: 3.2 mut/Mb."

prostate_008:
  morphology: NEUROENDOCRINE
  descriptive_name: Treatment-emergent neuroendocrine prostate cancer
  biomarker_profile: "TP53 truncating mutation (p.E204*). RB1 loss. PTEN deletion. AR amplification absent."

prostate_009:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate ca
  biomarker_profile: "TMB-H (15 mut/Mb)."

prostate_010:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic carcinoma
  biomarker_profile: "PALB2 germline pathogenic variant c.3113G>A (p.W1038*) identified. Recommend cascade testing for family members."

prostate_011:
  morphology: ADENOCARCINOMA
  descriptive_name: High-grade prostatic adenocarcinoma
  biomarker_profile: "Microsatellite stable. No HR gene mutations detected."

prostate_012:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma, Gleason 9
  biomarker_profile: "BRCA2 K3226* nonsense mutation. TP53 Y220C. MSI-L. TMB intermediate (8 mut/Mb)."

prostate_013:
  morphology: ADENOCARCINOMA
  descriptive_name: mCRPC
  biomarker_profile: "NGS panel: BRCA1 negative, BRCA2 negative, ATM p.R2227C VUS, PALB2 negative."

prostate_014:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: SCNC prostate
  biomarker_profile: "TP53 null mutation identified."

prostate_015:
  morphology: ADENOCARCINOMA
  descriptive_name: Ductal adenocarcinoma of prostate
  biomarker_profile: "MSI testing: MSS. MMR intact by IHC. BRCA1/2 wild-type. TMB: 1.8."

prostate_016:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma
  biomarker_profile: "Somatic BRCA2 homozygous deletion detected by NGS. Germline testing pending."

prostate_017:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic adenocarcinoma
  biomarker_profile: "No mutations detected."

prostate_018:
  morphology: ADENOCARCINOMA
  descriptive_name: Advanced prostate cancer
  biomarker_profile: "TP53 p.R248W (VAF 67%). BRCA2 p.N1784fs*3 (VAF 41%). MSI-stable, TMB-low."

prostate_019:
  morphology: NEUROENDOCRINE
  descriptive_name: Neuroendocrine differentiation of prostate
  biomarker_profile: "TP53 splice site mutation c.376-1G>A."

prostate_020:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate ADC
  biomarker_profile: "PALB2 c.2386G>T pathogenic."

prostate_021:
  morphology: ADENOCARCINOMA
  descriptive_name: Castration-sensitive prostate cancer
  biomarker_profile: "Liquid biopsy: BRCA2 p.S1982fs detected in ctDNA. MSI not detected."

prostate_022:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic carcinoma
  biomarker_profile: "TMB 22 mut/Mb (high). MSI-H confirmed. MLH1 promoter hypermethylation present."

prostate_023:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate cancer
  biomarker_profile: "BRCA1/BRCA2/PALB2/TP53 all negative by targeted sequencing."

prostate_024:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Small cell prostatic carcinoma
  biomarker_profile: "TP53 p.G245S mutation. Synaptophysin+, chromogranin+, PSA negative."

prostate_025:
  morphology: ADENOCARCINOMA
  descriptive_name: Adenocarcinoma of the prostate
  biomarker_profile: "BRCA2 VUS p.I2627V - clinical significance unknown."

prostate_026:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenoca
  biomarker_profile: "MSI-high."

prostate_027:
  morphology: ADENOCARCINOMA
  descriptive_name: Metastatic prostate adenocarcinoma
  biomarker_profile: "Germline testing: BRCA1 c.68_69del pathogenic variant identified. Somatic: TP53 R273C, PTEN loss."

prostate_028:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate carcinoma
  biomarker_profile: "FoundationOne CDx: No targetable alterations. TMB-L (3 mut/Mb), MSS."

prostate_029:
  morphology: NEUROENDOCRINE
  descriptive_name: NEPC
  biomarker_profile: "TP53 p.R248Q detected at high allele frequency (78%)."

prostate_030:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic adenocarcinoma, acinar type
  biomarker_profile: "PALB2 germline mutation c.1592delT confirmed. Genetic counseling recommended."

prostate_031:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate Ca
  biomarker_profile: "BRCA2 neg."

prostate_032:
  morphology: ADENOCARCINOMA
  descriptive_name: High-risk localized prostate cancer
  biomarker_profile: "MSI stable by PCR. MMR proficient. No HRR gene alterations detected."

prostate_033:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma
  biomarker_profile: "Tumor mutational burden: 11.3 mut/Mb (intermediate-high). MSI-indeterminate."

prostate_034:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: De novo small cell carcinoma of prostate
  biomarker_profile: "TP53 frameshift mutation p.P152fs*18. RB1 deletion. PTEN homozygous loss."

prostate_035:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma
  biomarker_profile: "BRCA1 wild-type, BRCA2 wild-type, PALB2 wild-type, TP53 wild-type."

prostate_036:
  morphology: ADENOCARCINOMA
  descriptive_name: mHSPC
  biomarker_profile: "BRCA2 genomic rearrangement detected (exons 12-14 deletion)."

prostate_037:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic adenocarcinoma
  biomarker_profile: "MSI-H, TMB 28 mutations/Mb. PD-L1 CPS 15."

prostate_038:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate cancer, Grade Group 5
  biomarker_profile: "No clinically significant variants identified in 50-gene panel."

prostate_039:
  morphology: NEUROENDOCRINE
  descriptive_name: Mixed adenocarcinoma-neuroendocrine prostate
  biomarker_profile: "TP53 p.Y163C (clonal). AR-V7 positive in CTCs."

prostate_040:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate ADC
  biomarker_profile: "TMB low."

prostate_041:
  morphology: ADENOCARCINOMA
  descriptive_name: Recurrent prostate carcinoma
  biomarker_profile: "PALB2 p.Q921* germline pathogenic variant. MSS. TMB 4.1 mut/Mb."

prostate_042:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic carcinoma
  biomarker_profile: "Liquid biopsy negative for actionable alterations. Microsatellite stable."

prostate_043:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma
  biomarker_profile: "BRCA2 p.E1493* somatic mutation. TP53 p.H179R. HRD score positive."

prostate_044:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Small cell/neuroendocrine prostate cancer
  biomarker_profile: "TP53 c.818G>A."

prostate_045:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate cancer
  biomarker_profile: "MSI: Stable. TMB: Not elevated (2.5 mut/Mb)."

prostate_046:
  morphology: ADENOCARCINOMA
  descriptive_name: Hormone-sensitive prostate cancer
  biomarker_profile: "Germline panel: BRCA1 c.5266dupC pathogenic. Recommend family screening."

prostate_047:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic adenoca
  biomarker_profile: "All markers negative."

prostate_048:
  morphology: ADENOCARCINOMA
  descriptive_name: Metastatic prostate adenocarcinoma
  biomarker_profile: "BRCA2 biallelic inactivation (germline p.K944* + LOH). MSI-L, TMB 5 mut/Mb."

prostate_049:
  morphology: NEUROENDOCRINE
  descriptive_name: Prostatic neuroendocrine carcinoma
  biomarker_profile: "TP53 deletion exons 2-11 detected by MLPA."

prostate_050:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate
  biomarker_profile: "PALB2-."

prostate_051:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic adenocarcinoma, ductal variant
  biomarker_profile: "MSH2 loss by immunohistochemistry. MSI-H by PCR. TMB elevated."

prostate_052:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate carcinoma
  biomarker_profile: "Somatic testing: BRCA2 p.S1982Rfs*22, TP53 p.C176F, PTEN deletion."

prostate_053:
  morphology: ADENOCARCINOMA
  descriptive_name: Localized prostate cancer
  biomarker_profile: "No mutations in HRR pathway genes."

prostate_054:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Transformed SCNC
  biomarker_profile: "TP53 missense mutation p.R175H detected. NE markers: NSE elevated, CD56 positive."

prostate_055:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma
  biomarker_profile: "TMB-high (14 mut/Mb). MSI-stable. No BRCA1/2 mutations."

prostate_056:
  morphology: ADENOCARCINOMA
  descriptive_name: Castration-resistant prostate
  biomarker_profile: "BRCA1 promoter methylation detected. PALB2 WT. TP53 WT."

prostate_057:
  morphology: ADENOCARCINOMA
  descriptive_name: PCa
  biomarker_profile: "MSI-H."

prostate_058:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma, Gleason 7
  biomarker_profile: "Comprehensive genomic profiling: No actionable variants. TMB 1.2 mut/Mb (low)."

prostate_059:
  morphology: NEUROENDOCRINE
  descriptive_name: Aggressive variant prostate cancer
  biomarker_profile: "TP53 p.V157F mutation (VAF 89%). RB1 loss confirmed."

prostate_060:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma
  biomarker_profile: "PALB2 c.3256C>T (p.R1086*) germline pathogenic variant."

prostate_061:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate cancer
  biomarker_profile: "BRCA2 and PALB2 testing negative."

prostate_062:
  morphology: ADENOCARCINOMA
  descriptive_name: Oligometastatic prostate cancer
  biomarker_profile: "BRCA2 c.9097dupA detected in tumor tissue. Germline confirmation pending."

prostate_063:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic carcinoma
  biomarker_profile: "MSS, TMB-L."

prostate_064:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Pure small cell carcinoma of prostate
  biomarker_profile: "TP53 p.R280K. TTF1 negative, NKX3.1 negative."

prostate_065:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma
  biomarker_profile: "HRR gene panel all wild-type. Microsatellites stable."

prostate_066:
  morphology: ADENOCARCINOMA
  descriptive_name: CRPC
  biomarker_profile: "BRCA1 p.M1V pathogenic variant (somatic). TP53 p.G245D. MSI-stable, TMB 7 mut/Mb."

prostate_067:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate
  biomarker_profile: "No alterations."

prostate_068:
  morphology: ADENOCARCINOMA
  descriptive_name: Intraductal carcinoma of prostate
  biomarker_profile: "PALB2 splice site mutation c.3350+1G>A. BRCA1/2 negative."

prostate_069:
  morphology: NEUROENDOCRINE
  descriptive_name: Neuroendocrine prostate cancer
  biomarker_profile: "TP53 nonsense mutation p.Q192*."

prostate_070:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma
  biomarker_profile: "TMB: 3 mutations/megabase."

prostate_071:
  morphology: ADENOCARCINOMA
  descriptive_name: Node-positive prostate cancer
  biomarker_profile: "Germline: BRCA2 p.Y1655* pathogenic. Somatic: TP53 p.P72R, MSS."

prostate_072:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic adenocarcinoma
  biomarker_profile: "MSI-high detected. MLH1/PMS2 absent on IHC. BRAF V600E negative."

prostate_073:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate Ca
  biomarker_profile: "Wild-type for all tested genes."

prostate_074:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Neuroendocrine prostate carcinoma, small cell type
  biomarker_profile: "TP53 p.C238Y mutation identified by targeted NGS."

prostate_075:
  morphology: ADENOCARCINOMA
  descriptive_name: Biochemically recurrent prostate cancer
  biomarker_profile: "ctDNA analysis: BRCA2 p.Q2829* detected at 2.3% VAF."

prostate_076:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma
  biomarker_profile: "PALB2 VUS p.G998E - significance uncertain. MSI stable."

prostate_077:
  morphology: ADENOCARCINOMA
  descriptive_name: mCRPC
  biomarker_profile: "TMB-H (19 mut/Mb), MSI-H."

prostate_078:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic carcinoma, acinar
  biomarker_profile: "No HRD detected. BRCA1/BRCA2/PALB2 intact."

prostate_079:
  morphology: NEUROENDOCRINE
  descriptive_name: Treatment-related NEPC
  biomarker_profile: "TP53 p.R282W (clonal, 92% VAF)."

prostate_080:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma
  biomarker_profile: "BRCA1 c.212+3A>G splice variant (likely pathogenic)."

prostate_081:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate
  biomarker_profile: "MSI-stable."

prostate_082:
  morphology: ADENOCARCINOMA
  descriptive_name: High-volume metastatic prostate cancer
  biomarker_profile: "BRCA2 homozygous deletion. TP53 p.R175H. ATM p.R337C. TMB 8.5 mut/Mb."

prostate_083:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic adenocarcinoma
  biomarker_profile: "Mismatch repair proficient. TMB low (1.5 mut/Mb)."

prostate_084:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Mixed adenocarcinoma-small cell carcinoma
  biomarker_profile: "TP53 frameshift p.L194fs. PSA low, chromogranin A markedly elevated."

prostate_085:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate cancer, Grade Group 4
  biomarker_profile: "PALB2 p.L939W germline VUS. Clinical significance unknown."

prostate_086:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate ADC
  biomarker_profile: "BRCA2-negative."

prostate_087:
  morphology: ADENOCARCINOMA
  descriptive_name: Metastatic hormone-naive prostate cancer
  biomarker_profile: "Liquid biopsy: BRCA2 p.S1882* detected. Germline testing confirmed pathogenic."

prostate_088:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic carcinoma
  biomarker_profile: "TMB intermediate (6 mut/Mb). MSS. No HRR alterations."

prostate_089:
  morphology: NEUROENDOCRINE
  descriptive_name: Large cell neuroendocrine carcinoma of prostate
  biomarker_profile: "TP53 c.733G>A (p.G245S) somatic mutation."

prostate_090:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma
  biomarker_profile: "MSI-H confirmed by NGS. TMB 24 mut/Mb. MSH6 germline mutation p.F1088fs."

prostate_091:
  morphology: ADENOCARCINOMA
  descriptive_name: Localized high-risk prostate
  biomarker_profile: "All biomarkers within normal limits."

prostate_092:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate carcinoma
  biomarker_profile: "BRCA1 methylation absent. BRCA2 intact. PALB2 intact. TP53 p.Y220C."

prostate_093:
  morphology: ADENOCARCINOMA
  descriptive_name: PCa
  biomarker_profile: "TMB 2 mut/Mb."

prostate_094:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: De novo neuroendocrine prostate
  biomarker_profile: "TP53 homozygous deletion detected by FISH."

prostate_095:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma, post-radiation
  biomarker_profile: "PALB2 c.1240C>T (p.R414*) germline pathogenic variant detected."

prostate_096:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostatic adenocarcinoma
  biomarker_profile: "Guardant360: No detectable ctDNA alterations."

prostate_097:
  morphology: ADENOCARCINOMA
  descriptive_name: Metastatic prostate cancer to bone
  biomarker_profile: "BRCA2 p.K3326* pathogenic (germline origin confirmed). MSI-L, TMB 4.8."

prostate_098:
  morphology: NEUROENDOCRINE
  descriptive_name: Prostatic neuroendocrine tumor
  biomarker_profile: "TP53 p.H193R detected."

prostate_099:
  morphology: ADENOCARCINOMA
  descriptive_name: Prostate adenocarcinoma
  biomarker_profile: "MSH2/MSH6 intact, MLH1/PMS2 intact by IHC. MSS by PCR. TMB-low."

prostate_100:
  morphology: ADENOCARCINOMA
  descriptive_name: CRPC with visceral metastases
  biomarker_profile: "Comprehensive profiling: BRCA2 c.5722_5723del, TP53 p.V272M, RB1 loss, PTEN deletion. MSI-stable, TMB 9.2 mut/Mb."